BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics
NCT07633366 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2026-07-10
Summary
Acute respiratory distress syndrome (ARDS) is a major contributor to ICU mortality and is characterised by hypoxaemia and pulmonary oedema. Pathomechanisms include barrier breakdown, immunopathology, haemostatic derailment and dysbiosis; however, the actual sequence of events and how they cumulatively lead to lung failure remains unclear. Although ARDS is frequently triggered by pneumonia, it can also occur as a result of trauma, aspiration or non-pulmonary causes. Importantly, ARDS is highly heterogeneous; growing evidence points to aetiology-specific pathomechanisms - a circumstance that explains why attempts to develop specific drugs or timely diagnostic markers have so far failed.
A comprehensive analysis of key microenvironmental and haemostasis-related parameters of the lung, combined with multidimensional quantitative image features derived from chest CT scans (radiomics), will enable us to i) identify ARDS phenotypes with different biological characteristics and ii) generate new hypotheses regarding aetiology- or subgroup-specific mechanisms, molecular markers and therapeutic options.
Our approach is based on ICU management of our patients guided by bronchoalveolar lavage fluid (BALF). Together with previously sampled cases and new samples collected as part of this study, our cohort will consist of patients with i) COVID-19-associated ARDS, ii) ARDS associated with other viral pneumonia, iii) ARDS associated with bacterial pneumonia, and iv) ARDS of non-pulmonary origin. Bacterial and fungal co-infections and superinfections are recorded in all patients and taken into account in the stratification. Patients with pneumonia without ARDS, as well as ventilated patients without underlying lung disease, serve as controls. To characterise the microbial lung microenvironment, the investigators combine data from routine microbiological diagnostics with microbiome sequencing and metabolomics. In addition, the investigators conduct comprehensive and longitudinal immune and haemostatic profiling by regularly analysing immune cells, cytokines and parameters of immune thrombosis in BALF and blood. Multi-omics integration then identifies phenotypic subgroups by merging all multimodal datasets - including radiomics. Selected samples from identified clusters are then further characterised using single-cell sequencing to uncover specific features/markers and pathomechanisms of the respective ARDS subtypes.
Although it is clear that the pathogenesis of ARDS is multifactorial, comprehensive studies that integrate all relevant parameters are rare. Radiomics is increasingly recognised as a powerful tool for capturing the clinical status of ARDS in detail; however, to date, this imaging data has not been systematically linked to other omics readouts. The investigators aim to bridging this gap by conducting a thorough investigation across various ARDS aetiologies in the present study, incorporating all identifiable key factors.
Our interdisciplinary team comprises basic immunologists, infectious disease and computational biologists, as well as clinicians with expertise in ARDS, infectious diseases, immunothrombosis and radiology.
Conditions
- ARDS (Acute Respiratory Distress Syndrome)
Interventions
- DIAGNOSTIC_TEST
-
sampling blood
blood will be drawn from patients on day 1 and once a week until discharge/withdrawal/death
- DIAGNOSTIC_TEST
-
Lavage with physiologic saline solution
mini-BALF using a physiologic saline soluation will be performed on day 1 and once a week until discharge/withdrawal/death
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Oliver Robak, Prof. PD Dr. · Medical University of Vienna, Department of Medicine 1
-
Riem Gawish, PhD · Medical University of Vienna, Department of Medicine 1
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2029-06-01
- Completion
- 2030-06-01
Countries
- Austria
Study Locations
More Related Trials
-
Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome
NCT07395076 ·Status: RECRUITING
-
Ultraprotective Lung Ventilation With Respiratory Extracorporeal Life Support for ARDS
NCT07516665 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Physiological Study of Prone Position in Acute Respiratory Failure Syndrome
NCT06061796 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Lung Recruitment and End-expiratory Lung Collapse in Acute Respiratory Distress Syndrome (ARDS)
NCT01670747 ·Status: COMPLETED
-
Exploration of Diagnosis and Treatment Strategies and Prognostic Prediction Models for Acute Respiratory Distress Syndrome Based on Radiographic Evaluations Assessed by Artificial Intelligence
NCT07328997 ·Status: COMPLETED
-
Proteinuria During Sepsis and Septic Shock: Characterization and Association With ARDS
NCT06476860 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940 ·Status: RECRUITING
-
Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes
NCT05451342 ·Status: UNKNOWN
-
Quantitative Computed Tomography for Mortality Risk Stratification in ARDS
NCT06113276 ·Status: RECRUITING
-
Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome
NCT06430619 ·Status: COMPLETED
-
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
NCT06272942 ·Status: COMPLETED
-
Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
NCT03546699 ·Status: UNKNOWN
-
Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients
NCT05371314 ·Status: UNKNOWN
-
The Role of Elastic Power in Predicting the Severity and Mortality in Adult Patients With ARDS Due to Pneumonia
NCT06477861 ·Status: RECRUITING
-
Low Dose Lung CT Scan for Quantitative Analysis in ARDS Patients
NCT01926093 ·Status: COMPLETED
-
Functional Respiratory Imaging of Airways in ARDS
NCT03309085 ·Status: COMPLETED ·Phase: NA
-
ARDS Caused by COVID-19
NCT04368975 ·Status: UNKNOWN
-
Tetracycline to Limit the Innate Immune Response in Acute Respiratory Distress Syndrome
NCT04079426 ·Status: UNKNOWN
-
Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)
NCT02070666 ·Status: TERMINATED ·Phase: NA
-
Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU Patients
NCT00811629 ·Status: COMPLETED
-
Maneuver for Evaluating the Potential Recruitability of the Pulmonary Parenchyme in Patients With ARDS
NCT04387669 ·Status: UNKNOWN
-
Biomarkers to Predict Acute Respiratory Distress Syndrome(ARDS) in Patients With Sepsis
NCT05914428 ·Status: UNKNOWN
-
SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome
NCT06774534 ·Status: RECRUITING
-
Assessment of Organ Failure Risk Predictions in ICU
NCT06814327 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System
NCT04008225 ·Status: COMPLETED